Ontabas, Jason .
HRN: 24-70-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/24/2024
03/31/2024
IV
4.5g
Q8h
Congenital Heart Disease Prob VHD; PTB, New; R/o Pneumothorax; R/o CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes